Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Your RPS

RPS joins forces with professional bodies to tackle ‘chemical restraint’ prescribing

The RPS has joined forces with other professional bodies to tackle the over-prescribing of psychotopic drugs to adults with learning disabilities.

Signatories to the STOMPLD pledge, from left to right (back): Matt Hoghton; Ashok Roy; Ann Norman; Sandra Gidley; Peter Kinderman; Hazel Watson; front, Alistair Burt MP

Source: NHS England

Signatories to the STOMPLD pledge, from left to right (back): Matt Hoghton (Royal College of General Practitioners); Ashok Roy (Royal College of Psychiatry); Ann Norman (Royal College of Nursing); Sandra Gidley (Royal Pharmaceutical Society); Peter Kinderman (British Psychological Society); Hazel Watson (NHS England); (front): Alistair Burt MP

The Royal Pharmaceutical Society (RPS) has joined forces with NHS England, minister of state for community and social care Alistair Burt, and other professional bodies to launch a guidance document to support prescribers to review inappropriate prescriptions for psychotropic drugs in people with a learning disability and/or autism.

The guidance runs alongside a pledge to tackle the over-prescribing of psychotropic drugs that occurs in the case of an estimated 35,000 adults with learning disabilities.

“For far too long people with learning disabilities have received poor healthcare,” says Sandra Gidley, chair of the Royal Pharmaceutical Society (RPS) English Pharmacy Board. “This group of patients are frequently prescribed antidepressants, sedatives and mood stabilisers in order to manage episodes of ill-health or challenging behaviour, which are not subsequently reviewed. These medicines can cause serious side effects, poor health and even premature death,” she adds.

The Stopping Over-Medication of People with a Learning Disability (STOMPLD) pledge has been signed by the Royal Colleges of Nursing, Psychiatrists and GPs, as well as the RPS, the British Psychological Society and NHS England at a summit in London on 1 June 2016. It commits each to “work together, and with people with a learning disability and their loved ones, to take real and measurable steps to stop over-medication”.

Bruce Keogh, national medical director at NHS England, says: “Reducing use of powerful drugs whenever we can is a good thing. We have managed this successfully in dementia; it’s now time to bring similar benefits to patients who have a learning disability.”

Gidley adds: “This pledge should act as a trigger to all health professionals to ensure that over-medication becomes a thing of the past. People with learning disabilities deserve better. A person-centred review should take place regularly and ideally every time a medicine is changed.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201242

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Prescribing Adult Intravenous Nutrition

    Prescribing Adult Intravenous Nutrition

    A practical guide to the principles and practice of adult intravenous nutrition. With numerous illustrations and case studies.

    £40.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons is the definitive reference source of analytical data for drugs and poisons.

    £535.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Signatories to the STOMPLD pledge, from left to right (back): Matt Hoghton; Ashok Roy; Ann Norman; Sandra Gidley; Peter Kinderman; Hazel Watson; front, Alistair Burt MP

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.